Close Menu

CIRM

CIRM Funds Dwindle

The California Institute for Regenerative Medicine is running out of funding, according to ScienceInsider.

Will They Renew?

As the California Institute for Regenerative Medicine runs out of funds, NPR asks whether states will again fund stem cell research.

The grant from the California Institute of Regenerative Medicine will fund research on two approaches to DMD gene therapy using CRISPR/Cas9.

NEW YORK (GenomeWeb) – Sangamo BioSciences today said that the California Institute for Regenerative Medicine has awarded $5.6 million grant to researchers at City of Hope to develop an HIV/AIDS therapeutic based on Sangamo's zinc finger nuclease genome editing technology.

NEW YORK (GenomeWeb News) – A review panel at the California Institute of Regenerative Medicine (CIRM) this week will decide whether to approve $40 million to fund several proposals to launch new research centers that would use genomics to pursue human biology, disease, and therapeutics studies.

NEW YORK (GenomeWeb News) – Stem cell developer Cellular Dynamics (CDI) will open a new facility within the Buck Institute for Research on Aging, in Novato, Calif., under a new five-year lease.

One award will be used to create methods of identifying potentially cancer-causing or other detrimental mutations in induced pluripotent stem cells, and the other will be used to conduct research into a group of genetic diseases.

Under the deal, BioTime will provide research-grade and GMP-grade cell lines to researchers in California.

Robert Wechsler-Reya would receive the first funding under the $44 million Leadership Award program of the California Institute for Regenerative Medicine if he finalizes an agreement by the end of June to move his laboratory and research in neural development and cancer stem cells to the Sanford-Burnham Medical Research Institute in La Jolla, Calif.

Leaders from TEDCO and CIRM agreed Monday to collaborate on conducting research and pursuing grant funding from state and federal sources in hopes of increasing their ability to compete with other top-tier states for researchers and their grant money.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.